Cohance Lifesciences Approves ESOP Grants and Allots 25,600 Equity Shares
Cohance Lifesciences Ltd 路 Others (Uncategorized) 路 06 Nov 2026, 6:44 pm
Cohance Lifesciences Approves ESOP Grants and Allots 25,600 Equity Shares On 6th Nov'26, Cohance Lifesciences approved the grant of 69,028 stock options under ESOP 2026 (exercise price minimum INR 325 or max 20% discount to 21-day average market price) and 1,03,542 stock options under ESOP 2023 at an exercise price of INR 495. Additionally, the company allotted 25,600 equity shares of INR 1 face value at an exercise price of INR 268 per share pursuant to ESOP 2023 exercises, expanding total issued share capital to 38,26,22,930 equity shares aggregating INR 38,26,22,930.
Original exchange filing (PDF)
More announcements from Cohance Lifesciences Ltd
- The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property and Equity Holdings .... 路 12 Nov 2026
- The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasub Property Holdings LLP & Others 路 12 Nov 2026
- Investors Meet 路 11 Nov 2026
- Transcript of Con call 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasub Property Holdings LLP & Others 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property and Equity Holdings Pvt Ltd & Others 路 11 Nov 2026
- Investor Presentation 路 07 Nov 2026
- Update on USFDA inspection at Pashamylaram Manufacturing facility. 路 07 Nov 2026
